Curing cancers with innovation and speed

Agenus is developing next-generation immunotherapeutics from its discovery platforms, providing the company with a deliberate balance between its wholly owned and partnered pipeline of novel therapies specifically designed to expand the benefit of immuno-oncology for patients with cancer.

Go to the profile of Agenus
Sep 12, 2019
Page of

No comments yet.